Skip to content
Screener

Bolt Biotherapeutics, Inc. BOLT Q1 2026 earnings

Reported May 12, 2026 · Before market open

Revenue$26.0KMiss by $1.5M
EPS-$4.31Miss by $1.46
Revenue estimate$1.5M
EPS estimate-$2.85

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$68.3K
EPS estimate-$3.89

FAQ

When did Bolt Biotherapeutics, Inc. report Q1 2026 earnings?
Bolt Biotherapeutics, Inc. (BOLT) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Bolt Biotherapeutics, Inc.'s Q1 2026 revenue and EPS?
Bolt Biotherapeutics, Inc. reported revenue of $26.0K and eps of $-4.31 for Q1 2026.
Did Bolt Biotherapeutics, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $1.5M by $1.5M. EPS missed the consensus estimate of $-2.85 by $1.46.
How did Bolt Biotherapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 97.9% from $1.2M a year earlier and eps grew 25.7% from $-5.80.
Where can I find Bolt Biotherapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-219361) and the 10-Q periodic report (0001193125-26-219382) directly on SEC EDGAR. The filing index links above go to sec.gov.